Covaxin - NewsroomPost

Covaxin safe for children aged 2-18 years, says Bharat Biotech

Covaxin safe for children aged 2-18 years, says Bharat Biotech

ANI

DCGI gives emergency use authorisation to Covaxin for 6-12 age group

DCGI gives emergency use authorisation to Covaxin for 6-12 age group

ANI

Bharat Biotech asked to provide more data on COVID-19 vaccine Covaxin for below 12-year-olds

Bharat Biotech asked to provide more data on COVID-19 vaccine Covaxin for below 12-year-olds

ANI

Covaxin supply suspension by WHO not to impact travel by people: MEA

Covaxin supply suspension by WHO not to impact travel by people: MEA

ANI

WHO suspension for Covaxin supply only for UN agencies: Sources

WHO suspension for Covaxin supply only for UN agencies: Sources

ANI

No impact on efficacy and safety of Covaxin: Bharat Biotech after WHO suspension

No impact on efficacy and safety of Covaxin: Bharat Biotech after WHO suspension

ANI

COVID-19 vaccine Covaxin now universal vaccine for adults, children: Bharat Biotech

COVID-19 vaccine Covaxin now universal vaccine for adults, children: Bharat Biotech

ANI

Covaxin can neutralise Delta, Omicron variants of coronavirus: Bharat Biotech

Covaxin can neutralise Delta, Omicron variants of coronavirus: Bharat Biotech

ANI

COVAXIN booster dose trial demonstrates long-term safety with no serious adverse events: Bharat Biotech

COVAXIN booster dose trial demonstrates long-term safety with no serious adverse events: Bharat Biotech

ANI

COVID-19: Bharat Biotech urges healthcare workers to ensure administration of only Covaxin to 15-18 years age group

COVID-19: Bharat Biotech urges healthcare workers to ensure administration of only Covaxin to 15-18 years age group

ANI

1
2
3
…
9
Next »

© 2024, All Rights Reserved by Headlong Newsroom Post India Private Limited